Navigation Links
Entrust Continues Leadership by Adding Support for Next-generation E-Passports
Date:10/1/2007

Advanced digital certificates help secure new biometrics to be stored on

next evolution of e-passports

DALLAS, Oct. 1 /PRNewswire-FirstCall/ -- Domestic and global security threats, coupled with rapidly emerging standards and technology, are leading governments across the world to pursue the issuance of more sophisticated machine readable travel documents (MRTDs) to their citizens. Entrust, Inc. (Nasdaq: ENTU), a leader in e-passport deployment and innovation, has announced the development of public key infrastructure (PKI) for the next generation of e-passport security, also known as Extended Access Control (EAC).

"Because we already help secure e-passports and national ID cards for governments around the world, it's only natural that Entrust plays a vital role in the development of this next level of e-passport technology," said Entrust Chairman, President and Chief Executive Officer Bill Conner. "As part of a layered security approach, Entrust PKI solutions help increase security, improve efficiency and promote cost-effectiveness to enable a more citizen-centric government."

EAC provides a higher level of security during the verification process of e-passports. Not based on the X.509 standard, EAC will leverage a new type of certificate established by the International Civil Aviation Organization (ICAO) known as a card verifiable (CV) certificate. Entrust is actively participating in the technical groups working on the new CV standard, including attending the Brussels Interoperability Group (BIG) meeting this week in Paris, France.

These next-generation e-passports will be required by all member European Union (EU) nations by June 2009. Deployment mandates for the U.S
'/>"/>

SOURCE Entrust, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Arctic coring expedition continues to yield new clues
2. Mine runoff continues to provide clues to microbial diversification
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. Adding radiation decreases breast cancer recurrence
5. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
6. Kinovate Life Sciences Launches Nittophase?High Performance Solid Support For Oligonucleatide Synthesis
7. Gene therapy promising for growing tooth-supporting bone
8. Cancer support cells may evolve, fuel tumor growth, study shows
9. New evidence supports century-old theory of cancer spread
10. Slow-frozen people? Latest research supports possibility of cyropreservation
11. Study supports urgent need for worldwide ban on lead-based paint

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ciphered the DNA codes, or genomes, of the famed f... The Genome 10K Project, an international effort t...on 10,000 species of animals for conducting compar... achieved. , Participating in The Genome 10K pro..., 2009 issue of the Journal of Heredity , are 70 ...
(Date:11/4/2009)...0 DigitalPersona, Inc., a leader i...s, today announced that WAND Corporation, a leadin...ck-service restaurants, has integrated DigitalPers...POS solutions. WAND,s quick-service customers can ...countability and deter unauthorized manager overri...
(Date:11/4/2009)...ire-FirstCall/ -- BIO-key International, Inc. (OTC...iometric identification software is showcasing don... conference being held at the New Orleans Conventi...ovide hands-on product demonstrations of its state...4. Also, at 5 PM on Monday, October 26, Peter Lux,...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3BIO-key(R) International Exhibiting at AABB TXPO 2New genetic research indicates Jewish priesthood has multiple lineages 10085 1New genetic research indicates Jewish priesthood has multiple lineages 10085 2Infant Head Flattening Linked to Ear Infections 58248 1Infant Head Flattening Linked to Ear Infections 58248 2Fructose Boosts Blood Pressure Studies Find 58246 1Fructose Boosts Blood Pressure Studies Find 58246 2Fructose Boosts Blood Pressure Studies Find 58246 3
...e in all shapes and sizes, from grand Redwood tree...hem, under the ground plants rely on a complex net... growth has been a mystery, but a new paper publis...pe of the existing root can determine how further ...mone concentration. The work also suggests that th...
...led warming over the last few decades has triggere...orth American and Western European lakes, say rese...stry of the Environment. , The team reports that ...te lakes similar to those previously observed in t... decades later. The Arctic has long been considere...
...ecember 22, 2008 - Shakespeare wrote "a rose by an...f the molecules that generate its,fragrance were t..., Assistant Professor of Chemistry at The City,Col...aboratory of Dr. Stuart,Firestein, Professor of Bi...te. Their findings, reported today in the journal ...
Other Biology News:Study links ecosystem changes in temperate lakes to climate warming 2Shape changes in aroma-producing molecules determine the fragrances we detect 2
(Date:11/6/2009)...PRNewswire/ -- Myriant Technologies LLC ("Myriant"...turer of renewable bio-chemicals, Uhde Corporatio... Uhde GmbH, one of the world,s leading engineering...ce for the engineering, procurement & construc...nts based on renewable feedstocks. The execution ...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. deliv...S® continuous delivery of exenatide) program ...Annual Diabetes Technology Meeting in San Francisc...n/prnh/20050301/SFTU126LOGO ) ,, Continuous S...ers Plasma Glucose, HbA1c and Reduces Weight in a ...
(Date:11/5/2009)...5 DSM Pharmaceutical Products toda...nce with Galenix, Saint Jean D,Illac, France, wher...acturing partner for Galenix commercial products o...borate on business development opportunities co-ma...on the strength of Galenix in drug product develop...
(Date:11/5/2009)... BioSpecifics Technologie...any developing first-in-class collagenase-based pr...the third quarter ended September 30, 2009. ,,...is year, the FDA,s Arthritis Advisory Committee un...oval of XIAFLEX(TM) for the treatment of Dupuytren...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
... The board of directors of Segetis,...rt as President and Chief Executive Officer of the...(Business Wire EON) September 3, 2008 -- Segetis ...al "binary code" for developing a wide r... ultimately derived from non-food agricultural and...
...CO, Sept. 3 Osprey Pharmaceuticals U.S.A., a,priv...tein therapeutics,that selectively target chemokin...itiating and maintaining inflammatory diseases, an...ion in its first round of venture capital,funding....articipation from,Novo Nordisk Biotech Fund (Novo ...
...., Sept. 3 Plexus Corp. (Nasdaq:,PLXS) announced ...ngzhou,China and has entered into an agreement to ...jiang Hi-Tech Park located in Hangzhou. The new,fa...stomers with regional,decision centers in the grea... to deliver a lowest total cost value proposition....
Other Biology Technology: Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc 2Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 2Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 3Plexus Announces Expansion in Hangzhou, China 2Plexus Announces Expansion in Hangzhou, China 3
Essential Data: Centrifugation from Promega
rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.
Rabbit anti-JLP AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Proteins LabFax from Promega
Biology Products: